{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Octreotide_Pamoate",
  "nciThesaurus": {
    "casRegistry": "135467-16-2",
    "chebiId": "",
    "chemicalFormula": "C49H66N10O10S2.C23H16O6",
    "definition": "A synthetic long-acting octapeptide analogue of endogenous somatostatin.  Octreotide pamoate binds to somatostatin receptors expressed by some neuroendocrine and non-neuroendocrine tumor cells, thereby initiating somatostatin receptor-mediated apoptosis. Other possible antineoplastic activities of this agent include suppression of tumor angiogenesis and tumor growth-promoting insulin-like growth factor 1 (IGF-1). ",
    "fdaUniiCode": "MWH8YQ1AIO",
    "identifier": "C2402",
    "preferredName": "Octreotide Pamoate",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [],
    "synonyms": [
      "OCTREOTIDE PAMOATE",
      "OP LAR",
      "Octreotide Embpnate",
      "Octreotide Pamoate",
      "Octreotide pamoate",
      "OncoLar",
      "SMS 201-995 PA",
      "SMS 201-995 pa LAR"
    ]
  }
}